Skip to main content

Developing Countries: Drugs

Question for Department for International Development

UIN 111579, tabled on 6 November 2017

To ask the Secretary of State for International Development, what steps her Department has taken to ensure that the Drugs for Neglected Diseases initiative provides for products that are affordable for patients.

Answered on

13 November 2017

DFID supports DNDi because its operational model puts the needs of patients at the heart of what it does and builds in equitable and affordable access to the end product from the outset. DNDi includes these approaches in its contractual relationships with industrial partners and by delinking the cost of the final product from the costs of research and development.

Interests declared
The Member has declared that they have interests which may be relevant to the subject matter of this question.